Literature DB >> 20954776

Cost-benefit analysis of multisystemic therapy with serious and violent juvenile offenders.

Stephanie J Klietz1, Charles M Borduin, Cindy M Schaeffer.   

Abstract

This study investigated the economics of multisystemic therapy (MST) versus individual therapy (IT) using rearrest data from a 13.7-year follow-up (Schaeffer & Borduin, 2005) of a randomized clinical trial with serious juvenile offenders (Borduin et al., 1995). Two types of benefits of MST were evaluated: The value to taxpayers was derived from measures of criminal justice system expenses (e.g., police and sheriff's offices, court processing, jails, community supervision), and the value to crime victims was derived in terms of both tangible (e.g., property damage and loss, health care, police and fire services, lost productivity) and intangible (e.g., pain, suffering, reduced quality of life) losses. Results indicated that the reductions in criminality in the MST versus IT conditions were associated with substantial reductions in expenses to taxpayers and intangible losses to crime victims, with cumulative benefits ranging from $75,110 to $199,374 per MST participant. Stated differently, it was estimated that every dollar spent on MST provides $9.51 to $23.59 in savings to taxpayers and crime victims in the years ahead. The economic benefits of MST, as well as its clinical effectiveness, should be considered by policymakers and the public at large in the selection of interventions for serious juvenile offenders.

Entities:  

Mesh:

Year:  2010        PMID: 20954776     DOI: 10.1037/a0020838

Source DB:  PubMed          Journal:  J Fam Psychol        ISSN: 0893-3200


  11 in total

1.  Measuring Costs to Community-Based Agencies for Implementation of an Evidence-Based Practice.

Authors:  Jason M Lang; Christian M Connell
Journal:  J Behav Health Serv Res       Date:  2017-01       Impact factor: 1.505

2.  Cost analysis of youth violence prevention.

Authors:  Adam L Sharp; Lisa A Prosser; Maureen Walton; Frederic C Blow; Stephen T Chermack; Marc A Zimmerman; Rebecca Cunningham
Journal:  Pediatrics       Date:  2014-02-10       Impact factor: 7.124

3.  Building Efficient Crime Prevention Strategies: Considering the Economics of Investing in Human Development.

Authors:  D Max Crowley
Journal:  Criminol Public Policy       Date:  2013-05

4.  Testing the role of adolescent sexual initiation in later-life sexual risk behavior: a longitudinal twin design.

Authors:  Brooke M Huibregtse; Marina A Bornovalova; Brian M Hicks; Matt McGue; William Iacono
Journal:  Psychol Sci       Date:  2011-06-03

Review 5.  Systematic Review of Violence Prevention Economic Evaluations, 2000-2019.

Authors:  Cora Peterson; Megan C Kearns
Journal:  Am J Prev Med       Date:  2021-02-16       Impact factor: 5.043

Review 6.  Multisystemic therapy for child non-externalizing psychological and health problems: a preliminary review.

Authors:  Heather T Pane; Rachel S White; Michael R Nadorff; Amie Grills-Taquechel; Melinda A Stanley
Journal:  Clin Child Fam Psychol Rev       Date:  2013-03

7.  Where is the Child in Family Therapy Service After Family Violence? A Study from the Norwegian Family Protection Service.

Authors:  Anna Margrete Flåm; Bjørn Helge Handegård
Journal:  Contemp Fam Ther       Date:  2015

Review 8.  Return on investment of public health interventions: a systematic review.

Authors:  Rebecca Masters; Elspeth Anwar; Brendan Collins; Richard Cookson; Simon Capewell
Journal:  J Epidemiol Community Health       Date:  2017-03-29       Impact factor: 3.710

Review 9.  Systematic review of economic evaluations of interventions for high risk young people.

Authors:  Kim Edmunds; Rod Ling; Anthony Shakeshaft; Chris Doran; Andrew Searles
Journal:  BMC Health Serv Res       Date:  2018-08-23       Impact factor: 2.655

10.  Cost-effectiveness of Multisystemic Therapy for adolescents with antisocial behaviour: study protocol of a randomized controlled trial.

Authors:  Danielle E M C Jansen; Karin M Vermeulen; Annemieke H Schuurman-Luinge; Erik J Knorth; Erik Buskens; Sijmen A Reijneveld
Journal:  BMC Public Health       Date:  2013-04-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.